Article
An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo.
Journal of virology - 1 Dec 1997
Ethelberg S, Sørensen A B, Schmidt J, Luz A, Pedersen F S
Abstract excerpt
SL3-3 is a highly T-lymphomagenic murine retrovirus in which the transcriptional enhancer is a major oncogenic determinant. Here, we describe an SL3-3 enhancer variant that induced T-cell lymphomas in all inoculated mice with a shorter latency period than wild-type SL3-3. The enhancer repeat region of this variant contains two deletions encompassing the nuclear factor 1 binding sites in addition to an additional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
